Summary
Bristol-Myers Squibb Company (BMY) announced a significant change to its 2020 Annual Meeting of Stockholders due to the ongoing COVID-19 pandemic. The meeting, originally scheduled for May 5, 2020, will now be held as a virtual-only event. This decision prioritizes the health and safety of stockholders and employees by eliminating the need for in-person attendance. Investors should note that this shift to a virtual format means stockholders will not be able to attend the meeting physically. All necessary information and participation details for the virtual meeting can be found in the company's press release dated April 14, 2020, and a related proxy supplement filed with the SEC. This change is purely logistical and does not reflect any operational or financial developments within the company.
Key Highlights
- 1Bristol-Myers Squibb (BMY) is moving its 2020 Annual Meeting of Stockholders to a virtual-only format.
- 2The change is a direct response to public health concerns surrounding the COVID-19 pandemic.
- 3The Annual Meeting will still take place on Tuesday, May 5, 2020, at 10:00 a.m. Eastern Time.
- 4Stockholders will not be able to attend the meeting in person.
- 5Details regarding the virtual meeting format and participation are available in a press release dated April 14, 2020, and a proxy supplement filed with the SEC.
- 6This announcement is primarily an update on meeting logistics and not an indicator of financial or operational changes.